Patented single-use filtration device uses ion exchange resin technology to selectively reduce sulfite and histamine ...
Viking Therapeutics completes enrollment in its phase III VANQUISH-1 obesity study, surpassing targets and marking rapid ...
Cash and cash equivalents totaled €119.0 million as of September 30, 2025€39.2 million in revenues for the nine months ended September 30, 2025, including the €26.5 million milestone payment following ...
FSSAI orders removal of non-compliant drinks falsely labelled as “ORS”, targeting deceptive marketing and protecting ...
The emerging prevalence of digitalization is a key topic for manufacturers handling excipients. Digital transformation and data integrity protocols are crucial strategies for optimizing drug ...
Malawi's war against malaria has received a powerful new weapon following the World Health Organization's approval of the first-ever child-friendly, transmission-blocking formulations of primaquine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback